Inequitable access to biotechnological advances can deepen social divides:
Healthcare Disparities: Advanced treatments, such as gene therapy and personalized medicine, may be out of reach for marginalized communities, leading to unequal health outcomes. Global Inequality: Developing countries may lack the resources to invest in biotechnology, widening the gap between rich and poor nations. Educational Barriers: Access to education and training in biotechnology fields may be limited for certain groups, restricting their participation in this growing sector.
